Progression of early postnatal retinal pathology in a mouse model of neuronal ceroid lipofuscinosis

Eye

Volumn 19, Issue 12, 2005, Pages 1306-1312

  Seigel, G M ^a   Wagner, J ^b   Wronska, A ^c   Campbell, L ^a   Ju, W ^c   Zhong, N ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Apoptosis; Lipofuscinosis; Pathology; Retinal degeneration

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOFLUORESCENCE; CELL DEATH; CELL INCLUSION; CONTROLLED STUDY; DISEASE COURSE; MORPHOMETRICS; MOUSE; NEURONAL CEROID LIPOFUSCINOSIS; NICK END LABELING; NONHUMAN; PERINATAL PERIOD; PERIODIC ACID SCHIFF STAIN; RETINA DISEASE; RETINA GANGLION CELL;

EID: 31444445870     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701770     Document Type: Article

References (30)

1. Herva R, Tynela J, Hirvasniemi A, Syrjakallio-Ylitalo M, Haltia M. Northern epilepsy: A novel form of neuronal ceroid lipofuscinosis. Brain Pathol 2000; 10: 215-222.
2. Ranta S, Zhang Y, Ross B, Lonka L, Takkunen E, Messer A et al. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 1999; 23(2): 233-236.
3. Lonka L, Kyttala A, Ranta S, Jalanko A, Lehesjoki AE. The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. Hum Mol Genetics 2000; 9(11): 1691-1697.
4. Messer A, Plummer J, Wong V, Lavail M. Retinal degeneration in motor neuron degeneration (mnd) mouse. Exp Eye Res 1993; 57: 637-641.
5. Chang B, Bronson RT, Hawes NL, Roderick TH, Peng C, Hageman GS et al. Retinal degeneration in motor neuron degeneration: A mouse model of ceroid lipofuscinosis. Invest Ophthalmol Vis Sci 1994; 35(3): 1071-1076.
6. Seigel GM, Lotery A, Kummer A, Bernard D, Greene NDE, Turmaine M et al. Retinal pathology and function in a cln3-knockout mouse model of juvenile ceroid lipofuscinosis (Batten Disease). Mol Cell Neurosci 2002; 19: 515-527.
7. Isenmann S, Kretza A, Cellerino A. Molecular determinants of retinal ganglion cell development, survival, and regeneration. Prog Ret Eye Res 2003; 22: 483-543.
8. Cooper JD, Messer A, Feng AK, Chua-Couzens J, Mobley WC. Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: Evidence for partial response to insulin-like growth factor-1 treatment. J Neurosci 1999; 19(7): 2556-2567.
9. Murnane RD, Prieur DJ, Ahern-Rindell AJ, Parish SM, Collier LL. The lesions of an ovine lysosomal storage disease. Initial characterization. Am J Pathol 1989; 134(2): 263-270.
10. Martin JJ, Libert J, Ceuterick C. Ultrastructure of brain and retina in Kufs' disease (adult type-ceroid-lipofuscinosis). Clin Neuropathol 1987; 6(6): 231-235.
11. Sappington RM, Pearce DA, Calkins DJ. Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis. Invest Ophthalmol Vis Sci 2003; 44(9): 3725-3731.
12. Persaud-Sawin DANW, VanDongen A, Boustany R. Motifs within the CLN3 protein: Modulation of cell growth rates and apoptosis. Hum Mol Genet 2002; 11(18): 2129-2142.
13. Carpenter S. Morphological diagnosis and misdiagnosis in Batten-kufs disease. Am J Med Genet Suppl 1988; 5: 85-91.
14. Goebel HH, Gullotta F, Bajanowski T, Hansen FJ, Braak H. Pigment variant of neuronal ceroid-lipofuscinosis. Am J Med Genet 1995; 57: 155-159.
15. Rapola J. Neuronal ceroid-lipofuscinoses in childhood. Perspect Pediatr Pathol 1993; 17: 7-44.
16. Hall NA, Lake BD, Dewji NN, Patrick AD. Lysosomal storage of subunit c of mitochondrial ATP synthase in Batten's disease (ceroid-lipofuscinosis). Biochem J 1991; 275: 269-272.
17. Palmer DN, Fearnley IM, Walker JE, Hall NA, Lake BD, Wolfe LS et al. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 1992; 42: 561-567.
18. Griffin JL, Muller R, Woograsingh R, Jowatt V, Hindmarsh A, Nicholson JK et al. Vitamin E deficiency and metabolic defects in neuronal ceroid lipofuscinosis described by bioinformatics. Physiol Genomics 2002; 11: 195-203.
19. Vance JE, Stone SJ, Faust JR. Abnormalities in mitochondria-associated membranes and phospholipid biosynthetic enzymes in the mnd/mnd mouse model of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 1997; 1344: 286-299.
20. Boriack RL, Cortinas E, Bennett MJ. Mitochondrial damage results in a reversible increase in lysosomal storage material in lymphoblasts from patients with juvenile neuronal ceroid-lipofuscinosis (Batten Disease). Am J Med Genet 1995; 57(2): 301-303.
21. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995; 1241: 139-176.
22. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
23. Carellia V, Ross-Cisnerosa FN, Saduna AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Ret Eye Res 2004; 23: 53-89.
24. Vrabec JP, Lieven CJ, Levin LA. Cell-type-specific opening of the retinal ganglion cell mitochondrial permeability transition pore. Invest Ophthalmol Vis Sci 2003; 44(6): 2774-2782.
25. Cai J, Nelson K, Wu M, Sternberg P, Jones DP. Oxidative damage and protection of the RPE. Prog Ret Eye Res 2000; 19(2): 205-221.
26. Messer A, Manley K, Plummer J. An early-onset strain of motor neuron degeneration (mnd) mutant mice. Mol Genet Metab 1999; 66: 393-397.
27. Ranta S, Lehesjoki AE. Northern epilepsy, a new member of the NCL family. Neurol Sci 2000; 21: S43-S47.
28. Sandbach J, Coscun P, Grossniklaus H, Kokoszka JE, Newman NJ, Wallace DC. Ocular pathology in mitochondrial superoxide dismutase (Sod2)-deficient mice. Invest Ophthalmol Vis Sci 2001; 42(10): 2173-2178.
29. Shamsi F, Boulton M. Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest Ophthalmol Vis Sci 2001; 42(12): 3041-3046.
30. Sundelin S, Nilsson S. Lipofuscin-formation in retinal pigment epithelial cells is reduced by anti-oxidants. Free Rad Biol Med 2001; 31(2): 217-225.